Svetlana Zozulya

Dr. Svetlana Zozulya

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 March 2021 in Psychiatry (Moscow) (Psikhiatriya)
Verified
Journal Article
Open access
PDF file
TKT. P. Klyushnik
T. P. Klyushnik
ASA. B. Smulevich
A. B. Smulevich
SZSvetlana Zozulya
Svetlana Zozulya
EVE. I. Voronova
E. I. Voronova
The objective: of the study was to present the main provisions of a new clinical and biological model of schizophrenia, which establishes links between disorders in the field of biological processes and the formation of positive and negative in the general psychopathological space of schizophrenia on the basis of the analysis of long-term results of clinical and biological research of the Mental Health Research Centre.Material and method: by keywords “schizophrenia”, “biological hypotheses of schizophrenia”, “neuroinflammation”, “neurodegeneration”; “positive disorders”, “negative disorders”, “neuroimmune relationships”, “catabolismof tryptophan”, “activation of microglia”, publications from PubMed/MEDLINE databases, RSCI and other sources were analyzedover the past 10 years in comparison with the results of clinical and biological studies of schizophrenia at the Mental Health Science Center.Results: comparison and analysis of current biological hypotheses of schizophrenia indicates that immunological studies are the most promising for solving the problem of establishing links between disorders of neurobiological processes and psychopathological specificities of schizophrenia. Within the framework of the new clinical and biological model, a key role is assigned to the process of neuroinflammation, which determines the pathogenesis of both negative and positive disorders by various, albeit interrelated, molecular mechanisms. One of these mechanisms, associated with the development of reversible positive symptom complexes, is based on an imbalance in the neurotransmitter systems, which is formed as a result of the effect of proinflammatory cytokines on tryptophan catabolism. Another mechanism that determines the development of negative symptom complexes is associated with the influence of cytotoxic metabolites on the processes of neurodegeneration. Conclusion: a new clinical and biological model of schizophrenia establishes a paradigm of the relationship between disorders in the sphere of biological processes determined by neuroinflammation/inflammation and the formation of the main procedural dimensions — positive and negative disorders in the general psychopathological space of schizophrenia. This model makes it possible to clarify some general provisions related to the pharmacotherapy of schizophrenia and the relief of negative disorders, and also serves as the basis for the development of new approaches to early diagnosis, clinical and social prognosis.

1 January 2021 in S.S. Korsakov Journal of Neurology and Psychiatry
Verified
Journal Article
Closed access
SZSvetlana Zozulya
Svetlana Zozulya
DTD.V. Tikhonov
D.V. Tikhonov
VKV.G. Kaleda
V.G. Kaleda
TKT.P. Klyushnik
T.P. Klyushnik
ЦЕЛЬ ИССЛЕДОВАНИЯ Изучение клинико-психопатологических и иммунологических особенностей становления ремиссии после первого психотического приступа в юношеском возрасте для определения закономерностей развития этого этапа и возможности использования полученных результатов для мониторинга, прогноза и оптимизации проведенной терапии. МАТЕРИАЛ И МЕТОДЫ Обследованы 50 пациентов мужского пола юношеского возраста — от 16 до 25 лет (средний возраст 20,8±2,2 года), перенесших первый эндогенный психотический приступ (F20, F25). Контрольная группа состояла из 45 здоровых юношей соответствующего возраста (средний возраст 19,2±3,2 года). Средний возраст манифестации психоза составил 19,8±2,5 дня. Клинико-психопатологическое, психометрическое (шкалы PANSS и HDRS) и иммунологическое обследование (технология Нейро-иммуно-тест) проводилось на высоте психотического состояния, в период редукции приступообразующей симптоматики и далее в течение 1—2 лет до полной редукции/значимого послабления психотических симптомов. РЕЗУЛЬТАТЫ В ходе проведенного исследования выделено три основных этапа становления ремиссии: I — этап редукции и модификации ведущей психотической симптоматики, II — этап стабилизации психических функций, III — этап реинтеграции психических функций. Показано, что каждому этапу становления ремиссии соответствуют различные особенности клинической симптоматики, а также определенные спектры иммунных маркеров (активности лейкоцитарной эластазы, α1-протеиназного ингибитора и уровня аутоантител к белку S100-B и основному белку миелина) в крови обследованных пациентов. Различия в спектрах иммунных показателей, наблюдаемые на II этапе становления ремиссии при выявлении у пациентов аффективных расстройств депрессивного полюса, определяют разные закономерности постприступного развития заболевания. Наиболее показательными являются иммунологические особенности III этапа формирования ремиссии. Динамика иммунных маркеров в ходе становления ремиссии может рассматриваться в качестве биологического критерия для оценки исхода первого приступа юношеского эндогенного психоза и полноты достигнутой ремиссии.

16 June 2024 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
Pupyshev A. B.Pupyshev A. B.
Pupyshev A. B.
AAAnna A. Akopyan
Anna A. Akopyan
MTMichael V. Tenditnik
Michael V. Tenditnik
MOMarina V. Ovsyukova
Marina V. Ovsyukova
NDNina I. Dubrovina
Nina I. Dubrovina
Maria A TikhonovaMaria A Tikhonova
Maria A Tikhonova
In the treatment of experimental neurodegeneration with disaccharide trehalose, various regimens are used, predominantly a 2% solution, drunk for several weeks. We studied the effects of different regimens of dietary trehalose treatment in an amyloid-β (Aβ) 25–35-induced murine model of Alzheimer’s disease (AD). Aβ-treated mice received 2% trehalose solution daily, 4% trehalose solution daily (continuous mode) or every other day (intermittent mode), to drink for two weeks. We revealed the dose-dependent effects on autophagy activation in the frontal cortex and hippocampus, and the restoration of behavioral disturbances. A continuous intake of 4% trehalose solution caused the greatest activation of autophagy and the complete recovery of step-through latency in the passive avoidance test that corresponds to associative long-term memory and learning. This regimen also produced an anxiolytic effect in the open field. The effects of all the regimens studied were similar in Aβ load, neuroinflammatory response, and neuronal density in the frontal cortex and hippocampus. Trehalose successfully restored these parameters to the levels of the control group. Thus, high doses of trehalose had increased efficacy towards cognitive impairment in a model of early AD-like pathology. These findings could be taken into account for translational studies and the development of clinical approaches for AD therapy using trehalose.

11 May 2021 in Biomolecules
Verified
Journal Article
Open access
PDF file
ATAnna Tkachev
Anna Tkachev
ESElena Stekolshchikova
Elena Stekolshchikova
NANickolay Anikanov
Nickolay Anikanov
SZSvetlana Zozulya
Svetlana Zozulya
ABAleksandra Barkhatova
Aleksandra Barkhatova
DPDaria Petrova
Daria Petrova
Schizophrenia is a serious mental disorder requiring lifelong treatment. While medications are available that are effective in treating some patients, individual treatment responses can vary, with some patients exhibiting resistance to one or multiple drugs. Currently, little is known about the causes of the difference in treatment response observed among individuals with schizophrenia, and satisfactory markers of poor response are not available for clinical practice. Here, we studied the changes in the levels of 322 blood plasma lipids between two time points assessed in 92 individuals diagnosed with schizophrenia during their inpatient treatment and their association with the extent of symptom improvement. We found 20 triglyceride species increased in individuals with the least improvement in Positive and Negative Syndrome Scale (PANSS) scores, but not in those with the largest reduction in PANSS scores. These triglyceride species were distinct from the rest of the triglyceride species present in blood plasma. They contained a relatively low number of carbons in their fatty acid residues and were relatively low in abundance compared to the principal triglyceride species of blood plasma.

1 July 2022 in Psychiatry (Moscow) (Psikhiatriya)
Verified
Journal Article
Open access
PDF file
TKT. P. Klyushnik
T. P. Klyushnik
ASA. B. Smulevich
A. B. Smulevich
VGV. Ye. Golimbet
V. Ye. Golimbet
SZSvetlana Zozulya
Svetlana Zozulya
EVE. I. Voronova
E. I. Voronova
К созданию клинико-биологической концепции шизофрении: соучастие хронического воспаления и генетической предиспозиции в формировании психопатологических расстройств

6 May 2023 in Psychiatry (Moscow) (Psikhiatriya)
Verified
Journal Article
Open access
PDF file
TKT. P. Klyushnik
T. P. Klyushnik
ASA. B. Smulevich
A. B. Smulevich
SZSvetlana Zozulya
Svetlana Zozulya
DRDmitry Vladimirovich Romanov
Dmitry Vladimirovich Romanov
VLV. M. Lobanova
V. M. Lobanova
Background: insufficient study of heterogeneous delusional disorders in schizophrenia and the role of inflammation in the development of the disease served as the basis for this study. The aim: to establish the role of immune mechanisms in the processes of the interaction of different forms of delusional symptom complexes in schizophrenia. Patients: 60 patients (mean age 38.4 ± 1.11 years) with the diagnosis “paranoid schizophrenia, continuous progressive course” (F20.00, ICD-10) were included in the study. The state of patients was defined by persistent delusional/hallucinatory delusional disorders. Based on the clinical assessment, patients were divided into three groups: 27 patients (group 1) with interpretative delusion, 22 patients (group 2) with delusion of influence based on the phenomena of mental automatism, and 11 examinees (group 3) with mixed forms of delusions (interpretative and delusions of influence with mental automatism). The control group consisted of 17 mentally and somatically healthy people, comparable with the patients by sex and age. Methods: inflammatory and autoimmune markers leukocyte elastase (LE) and α1-proteinase inhibitor (α1-PI) activity, leukocyte inhibitor index (LII) and antibody (aAb) level to S100B and MBP were determined in the blood. Results: in all groups of patients, an increase in the activity of LE and α1-PI was revealed compared with the control (p < 0.05). In group 2, an increase in aAb level to S100B was also detected (p < 0.05). Intra-group differences in LE activity served as the basis for dividing patients into three clusters. Cluster 1 was characterized by moderate activation of the immune system and was represented mainly by patients with interpretative delusions (54.5% of patients in the corresponding clinical group). Clusters 2 and 3 were distinguished by a higher level of immune system activation. A distinctive feature of cluster 3 was low LE activity against the background of high α1-PI activity and elevated level of aAb to S100B. Clusters 2 and 3 were represented mainly by patients with delusion of influence (74.1%). Сonclusion: the study confirmed the involvement of inflammation in the pathophysiology of delusional disorders in paranoid schizophrenia and allowed us to identify the relationship between the psychopathological structure of these disorders and the features of the spectrum of immune markers. The highest level of activation of the immune system, as well as immunological features presumably indicating impaired permeability of the blood-brain barrier, were associated mainly with delusions of influence with the phenomena of mental automatism.